Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 11/2013

01-11-2013 | Original Paper

Intron 3 of the ARID5B gene: a hot spot for acute lymphoblastic leukemia susceptibility

Authors: Ángela Gutiérrez-Camino, Elixabet López-López, Idoia Martín-Guerrero, José Sánchez-Toledo, Nagore García de Andoin, Ana Carboné Bañeres, Purificación García-Miguel, Aurora Navajas, África García-Orad

Published in: Journal of Cancer Research and Clinical Oncology | Issue 11/2013

Login to get access

Abstract

Purpose

Single-nucleotide polymorphisms (SNPs) in AT-rich interactive domain 5B (ARID5B) have been associated with risk for pediatric acute lymphoblastic leukemia (ALL). After reviewing previous studies, we realized that the most significant associations were restricted to intron 3, but the mechanism(s) by which those SNPs affect ALL risk remain to be elucidated. Therefore, the aim of this study was to analyze the association between genetic variants of the intron 3 region of ARID5B and the incidence of B-ALL in a Spanish population. We also aimed to find a functional explanation for the association, searching for copy number variations (CNVs), and changes in ARID5B expression associated with the genotypes of the SNPs.

Methods

We analyzed 10 SNPs in intron 3 of ARID5B in a Spanish population of 219 B-ALL patients and 397 unrelated controls with the Taqman Open Array platform. CNVs were analyzed in 23 patients and 17 controls using the Cytogenetics Whole-genome 2.7 M platform. Expression of ARID5B transcript 1 was quantified by qPCR and related to SNPs genotype in seven ALL cell lines.

Results

Association between intron 3 and B-ALL risk was confirmed for all of the SNPs evaluated in our Spanish population. We could not explain this association by the presence of CNVs. We neither detected changes in the expression of ARID5B isoform associated with the genotype of the SNPs.

Conclusions

The intron 3 of ARID5B gene was found to be strongly associated with B-ALL risk in the Spanish population examined. However, neither CNVs nor changes in mRNA expression were found to be responsible for this association.
Appendix
Available only for authorised users
Literature
go back to reference Bourquin JP, Subramanian A et al (2006) Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling. Proc Natl Acad Sci USA 103(9):3339–3344PubMedCrossRef Bourquin JP, Subramanian A et al (2006) Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling. Proc Natl Acad Sci USA 103(9):3339–3344PubMedCrossRef
go back to reference Chang LW, Payton JE et al (2008) Computational identification of the normal and perturbed genetic networks involved in myeloid differentiation and acute promyelocytic leukemia. Genome Biol 9(2):R38PubMedCrossRef Chang LW, Payton JE et al (2008) Computational identification of the normal and perturbed genetic networks involved in myeloid differentiation and acute promyelocytic leukemia. Genome Biol 9(2):R38PubMedCrossRef
go back to reference Ellinghaus E, Stanulla M et al (2012) Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia. Leukemia 26(5):902–909PubMedCrossRef Ellinghaus E, Stanulla M et al (2012) Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia. Leukemia 26(5):902–909PubMedCrossRef
go back to reference Gusev A, Lowe JK et al (2009) Whole population, genome-wide mapping of hidden relatedness. Genome Res 19(2):318–326PubMedCrossRef Gusev A, Lowe JK et al (2009) Whole population, genome-wide mapping of hidden relatedness. Genome Res 19(2):318–326PubMedCrossRef
go back to reference Han S, Lee KM et al (2010) Genome-wide association study of childhood acute lymphoblastic leukemia in Korea. Leuk Res 34(10):1271–1274PubMedCrossRef Han S, Lee KM et al (2010) Genome-wide association study of childhood acute lymphoblastic leukemia in Korea. Leuk Res 34(10):1271–1274PubMedCrossRef
go back to reference Healy J, Richer C et al (2010) Replication analysis confirms the association of ARID5B with childhood B-cell acute lymphoblastic leukemia. Haematologica 95(9):1608–1611PubMedCrossRef Healy J, Richer C et al (2010) Replication analysis confirms the association of ARID5B with childhood B-cell acute lymphoblastic leukemia. Haematologica 95(9):1608–1611PubMedCrossRef
go back to reference Huang L, Yu D et al (2012) Copy number variation at 6q13 functions as a long-range regulator and is associated with pancreatic cancer risk. Carcinogenesis 33(1):94–100PubMedCrossRef Huang L, Yu D et al (2012) Copy number variation at 6q13 functions as a long-range regulator and is associated with pancreatic cancer risk. Carcinogenesis 33(1):94–100PubMedCrossRef
go back to reference Johnston WT, Lightfoot TJ et al (2010) Childhood cancer survival: a report from the United Kingdom Childhood Cancer Study. Cancer Epidemiol 34(6):659–666PubMedCrossRef Johnston WT, Lightfoot TJ et al (2010) Childhood cancer survival: a report from the United Kingdom Childhood Cancer Study. Cancer Epidemiol 34(6):659–666PubMedCrossRef
go back to reference Klipper-Aurbach Y, Wasserman M et al (1995) Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus. Med Hypotheses 45(5):486–490PubMedCrossRef Klipper-Aurbach Y, Wasserman M et al (1995) Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus. Med Hypotheses 45(5):486–490PubMedCrossRef
go back to reference Lahoud MH, Ristevski S et al (2001) Gene targeting of Desrt, a novel ARID class DNA-binding protein, causes growth retardation and abnormal development of reproductive organs. Genome Res 11(8):1327–1334PubMedCrossRef Lahoud MH, Ristevski S et al (2001) Gene targeting of Desrt, a novel ARID class DNA-binding protein, causes growth retardation and abnormal development of reproductive organs. Genome Res 11(8):1327–1334PubMedCrossRef
go back to reference Lautner-Csorba O, Gézsi A et al (2012) Candidate gene association study in pediatric acute lymphoblastic leukemia evaluated by Bayesian network based Bayesian multilevel analysis of relevance. BMC Med Genomics 5:42PubMedCrossRef Lautner-Csorba O, Gézsi A et al (2012) Candidate gene association study in pediatric acute lymphoblastic leukemia evaluated by Bayesian network based Bayesian multilevel analysis of relevance. BMC Med Genomics 5:42PubMedCrossRef
go back to reference Lee PH, Shatkay H (2008) F-SNP: computationally predicted functional SNPs for disease association studies. Nucleic Acids Res 36(Database issue): D820–D824 Lee PH, Shatkay H (2008) F-SNP: computationally predicted functional SNPs for disease association studies. Nucleic Acids Res 36(Database issue): D820–D824
go back to reference Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402–408 Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402–408
go back to reference Lopez-Lopez E, Martin-Guerrero I et al (2011) Polymorphisms of the SLCO1B1 gene predict methotrexate-related toxicity in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 57(4):612–619PubMedCrossRef Lopez-Lopez E, Martin-Guerrero I et al (2011) Polymorphisms of the SLCO1B1 gene predict methotrexate-related toxicity in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 57(4):612–619PubMedCrossRef
go back to reference Orsi L, Rudant J et al (2012) Genetic polymorphisms and childhood acute lymphoblastic leukemia: GWAS of the ESCALE study (SFCE). Leukemia 26(12):2561–2564PubMedCrossRef Orsi L, Rudant J et al (2012) Genetic polymorphisms and childhood acute lymphoblastic leukemia: GWAS of the ESCALE study (SFCE). Leukemia 26(12):2561–2564PubMedCrossRef
go back to reference Pal S, Gupta R et al (2012) Alternative transcription and alternative splicing in cancer. Pharmacol Ther 136(3):283–294PubMedCrossRef Pal S, Gupta R et al (2012) Alternative transcription and alternative splicing in cancer. Pharmacol Ther 136(3):283–294PubMedCrossRef
go back to reference Papaemmanuil E, Hosking FJ et al (2009) Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet 41(9):1006–1010PubMedCrossRef Papaemmanuil E, Hosking FJ et al (2009) Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet 41(9):1006–1010PubMedCrossRef
go back to reference Pastorczak A, Górniak P et al (2011) Role of 657del5 NBN mutation and 7p12.2 (IKZF1), 9p21 (CDKN2A), 10q21.2 (ARID5B) and 14q11.2 (CEBPE) variation and risk of childhood ALL in the Polish population. Leuk Res 35(11):1534–1536PubMedCrossRef Pastorczak A, Górniak P et al (2011) Role of 657del5 NBN mutation and 7p12.2 (IKZF1), 9p21 (CDKN2A), 10q21.2 (ARID5B) and 14q11.2 (CEBPE) variation and risk of childhood ALL in the Polish population. Leuk Res 35(11):1534–1536PubMedCrossRef
go back to reference Paulsson K, Forestier E et al (2010) Genetic landscape of high hyperdiploid childhood acute lymphoblastic leukemia. Proc Natl Acad Sci USA 107(50):21719–21724PubMedCrossRef Paulsson K, Forestier E et al (2010) Genetic landscape of high hyperdiploid childhood acute lymphoblastic leukemia. Proc Natl Acad Sci USA 107(50):21719–21724PubMedCrossRef
go back to reference Perry GH, Ben-Dor A et al (2008) The fine-scale and complex architecture of human copy-number variation. Am J Hum Genet 82(3):685–695PubMedCrossRef Perry GH, Ben-Dor A et al (2008) The fine-scale and complex architecture of human copy-number variation. Am J Hum Genet 82(3):685–695PubMedCrossRef
go back to reference Prasad RB, Hosking FJ et al (2010) Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Blood 115(9):1765–1767PubMedCrossRef Prasad RB, Hosking FJ et al (2010) Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Blood 115(9):1765–1767PubMedCrossRef
go back to reference Samuelsson J, Alonso S et al (2011) Frequent somatic demethylation of RAPGEF1/C3G intronic sequences in gastrointestinal and gynecological cancer. Int J Oncol 38(6):1575–1577PubMed Samuelsson J, Alonso S et al (2011) Frequent somatic demethylation of RAPGEF1/C3G intronic sequences in gastrointestinal and gynecological cancer. Int J Oncol 38(6):1575–1577PubMed
go back to reference Treviño LR, Yang W et al (2009) Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet 41(9):1001–1005PubMedCrossRef Treviño LR, Yang W et al (2009) Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet 41(9):1001–1005PubMedCrossRef
go back to reference Vijayakrishnan J, Sherborne AL et al (2010) Variation at 7p12.2 and 10q21.2 influences childhood acute lymphoblastic leukemia risk in the Thai population and may contribute to racial differences in leukemia incidence. Leuk Lymphoma 51(10):1870–1874PubMedCrossRef Vijayakrishnan J, Sherborne AL et al (2010) Variation at 7p12.2 and 10q21.2 influences childhood acute lymphoblastic leukemia risk in the Thai population and may contribute to racial differences in leukemia incidence. Leuk Lymphoma 51(10):1870–1874PubMedCrossRef
go back to reference Xu H, Cheng C et al (2012) ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol 30(7):751–757PubMedCrossRef Xu H, Cheng C et al (2012) ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol 30(7):751–757PubMedCrossRef
go back to reference Yang W, Treviño LR et al (2010) ARID5B SNP rs10821936 is associated with risk of childhood acute lymphoblastic leukemia in blacks and contributes to racial differences in leukemia incidence. Leukemia 24(4):894–896PubMedCrossRef Yang W, Treviño LR et al (2010) ARID5B SNP rs10821936 is associated with risk of childhood acute lymphoblastic leukemia in blacks and contributes to racial differences in leukemia incidence. Leukemia 24(4):894–896PubMedCrossRef
Metadata
Title
Intron 3 of the ARID5B gene: a hot spot for acute lymphoblastic leukemia susceptibility
Authors
Ángela Gutiérrez-Camino
Elixabet López-López
Idoia Martín-Guerrero
José Sánchez-Toledo
Nagore García de Andoin
Ana Carboné Bañeres
Purificación García-Miguel
Aurora Navajas
África García-Orad
Publication date
01-11-2013
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 11/2013
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-013-1512-3

Other articles of this Issue 11/2013

Journal of Cancer Research and Clinical Oncology 11/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.